SELLAS Life Sciences Reports Second Quarter 2021 Financial
Reported Promising Updated Clinical Data in Ongoing Clinical Trials of Galinpepimut-S (GPS) in Combination with PD-1 Inhibitors for Malignant Pleural...
Source: globenewswire.com
Stay updated with breaking news from Published Outcomes Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Reported Promising Updated Clinical Data in Ongoing Clinical Trials of Galinpepimut-S (GPS) in Combination with PD-1 Inhibitors for Malignant Pleural...